Role of Dobutamine-Atropine Stress Echocardiography in Prognostic Evaluation of 300 Women

Echocardiography

Volumn 21, Issue 2, 2004, Pages 113-118

  Cordovil, Adriana ^a,b   Mathias Jr , Wilson ^a   Andrade, José Lázaro ^a   Campos Filho, Orlando ^a   Moisés, Valdir Ambrósio ^a   Gil, Manoel Adán ^a   Machado, Cristiano Vieira ^a   Arruda, Adelaide Maria ^a   Paiva, Marcelo Goulart ^a   Carvalho, Antonio C ^a   De Paola, Angelo A V ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Dobutamine; Echocardiography; Prognostic; Women

Indexed keywords

ATROPINE; DOBUTAMINE;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; ECHOCARDIOGRAPHY; EVALUATION; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; LITERATURE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; STRESS; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANGINA PECTORIS; ATROPINE; BRONCHODILATOR AGENTS; CARDIOTONIC AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ARTERIOSCLEROSIS; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE;

EID: 10744224691     PISSN: 07422822     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0742-2822.2004.03054.x     Document Type: Article

References (21)

1. Giuliani ER, Gersh BJ, McGoon MD, et al: Mayo Clinic - Practice of Cardiology, 3rd ed. Mosby, 1996.
2. Chaitman BR, Bourassa MG, Davis K, et al: Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS). Circulation 1981;64:360-367.
3. Detry JM, Kapita BM, Cosyns J, et al: Diagnostic value of history and maximal exercise electrocardiography in men and women suspected of coronary heart disease. Circulation 1977;56:756-761.
4. Picano E, Mathias W Jr, Pingitore A, et al: Safety and tolerability of dobutamine-atropine stress echocardiography: A prospective, multicentre study. Lancet 1994;344:1190-1192.
5. Bach DS, Heper A, Marcovitz PA, et al: Dobutamine stress echocardiography: Prevalence of a non-ischemic response in a low-risk population. Am Heart J 1993;125:1257-1261.
6. Secknus AM, Marwick TH: Influence of gender on physiologic response and accuracy of dobutamine echocardiography. Am J Cardiol 1997;80:721-724.
7. Elhendy A, Geleijnse ML, Van Domburg RT: Gender differences in the accuracy of dobutamine stress echocardiography for the diagnosis of coronary artery disease. Am J Cardiol 1997;80:1414-1418.
8. Lewis JF, Lin L, McGorray S, et al: Dobutamine stress echocardiography in women with chest pain. J Am Coll Cardiol 1999;33:1462-1468.
9. Cortigiani L, Dodi C, Paolini EA, et al: Prognostic value of pharmacological stress echocardiography in women with chest pain and unknown coronary artery disease. J Am Coll Cardiol 1998;32:1975-1981.
10. Davar JJ, Brull DJ, Bulugahipitiya S, et al: Prognostic value of negative dobutamine stress echo in women with intermediate probability of coronary artery disease. Am J Cardiol 1999;83:1. 100-102, a8.
11. Mesa A, Falcone M, Hernandez A, et al: Long-term prognosis in women with normal dobutamine stress echocardiography. Am J Cardiol 1999;83:7,1127-1129, a9.
12. Dodi C, Cortigiani L, Masini M, et al: The incremental prognostic value of pharmacological stress echo over exercise electrocardiography in women with chest pain of unknown origin. Eur Heart J 2001;22:145-152.
13. Diamond GA, Forrester JS: Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med 1979;300:1350-1358.
14. Picano E, Mathias W Jr, Pingitore A, et al: Safety and tolerability of dobutamine-atropine stress echocardiography: A prospective, multicentre study. Lancet 1994;344:1190-1192.
15. Shiller N, Shah P, Crawford M, et al: American Society of Echocardiography Committee on standards, subcommittee on quantitation of two-dimensional echocardiograms: Recommendations for quantitation of the left ventricle by two dimensional echocardiography. J Am Soc Echo 1989;2:358-367.
16. Poldermans D, Fiorette PM, Boersma E, et al: Dobutamine-atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease. Am J Med 1994;97:119-125.
17. Steiberg EH, Madmon L, Patel CP, et al: Long-term prognostic significance of dobutamine echocardiography in patients with suspected coronary artery disease: Results of a 5-year follow-up study. J Am Coll Cardiol 1997;29:969-973.
18. Naqui T, Hachamovich R, Dev V, et al: Does stress tc99m sestamibi/tl-201 myocardial spect predict the site of future acute myocardial infarction? Circulation 1994;90:545A
19. Varga A, Picano E, Cortigiani L, et al: On behalf of the EPIC (Echo Persantine International Cooperative Study) - EDIC (Echo Dobutamine International Cooperative Study) study groups. Is stress echocardiography capable to predict the site of future myocardial infarction? J Am Coll Cardiol 1996;28:45-51.
20. Ambrose JA, Tannembaum MA, Alexopoulos D, et al: Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988;12:56-62.
21. Borges AC, Pingitore A, Cordovil A, et al: Heterogeneity of left ventricular regional wall thickening following dobutamine infusion in normal human subjects. Eur Heart J 1995;16:1726-1730.